IRD
IRD
NASDAQ · Biotechnology

Opus Genetics Inc

$4.83
+0.28 (+6.15%)
As of Apr 1, 2:35 PM ET ·
Financial Highlights (FY 2025)
Revenue
29.54M
Net Income
-1,183,263
Gross Margin
47.3%
Profit Margin
-4.0%
Rev Growth
+3.0%
D/E Ratio
0.73
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 47.3% 47.3% 47.3%
Operating Margin -3.5% -3.5% -3.0%
Profit Margin -4.0% -4.0% -3.6%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 29.54M 29.63M 31.10M
Gross Profit 13.97M 14.01M 14.71M
Operating Income -1,038,040 -1,023,494 -939,153
Net Income -1,183,263 -1,185,756 -1,130,465
Gross Margin 47.3% 47.3% 47.3%
Operating Margin -3.5% -3.5% -3.0%
Profit Margin -4.0% -4.0% -3.6%
Rev Growth +3.0% +20.7% -3.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 68.97M 78.04M 72.81M
Total Equity 93.96M 103.70M 96.68M
D/E Ratio 0.73 0.75 0.75
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,626,848 -1,569,658 -1,729,159
Free Cash Flow -1,111,274 -1,455,645 -1,245,008